Oncosil Medical Ltd
ASX:OSL
Income Statement
Earnings Waterfall
Oncosil Medical Ltd
Revenue
|
355.3k
AUD
|
Cost of Revenue
|
-1.9m
AUD
|
Gross Profit
|
-1.5m
AUD
|
Operating Expenses
|
-10m
AUD
|
Operating Income
|
-11.5m
AUD
|
Other Expenses
|
-167.4k
AUD
|
Net Income
|
-11.7m
AUD
|
Income Statement
Oncosil Medical Ltd
Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||
Revenue |
2
N/A
|
2
+8%
|
2
+10%
|
2
+14%
|
2
-5%
|
1
-56%
|
0
-97%
|
0
+100%
|
0
+100%
|
0
+50%
|
0
-6%
|
0
-6%
|
0
-44%
|
0
+22%
|
0
+127%
|
2
+668%
|
3
+58%
|
5
+73%
|
4
-22%
|
3
-38%
|
4
+47%
|
5
+22%
|
5
+0%
|
5
+1%
|
4
-18%
|
3
-18%
|
3
-8%
|
2
-19%
|
1
-41%
|
1
-5%
|
1
-18%
|
1
-35%
|
0
-38%
|
0
-17%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
Gross Profit |
1
N/A
|
1
+13%
|
1
+9%
|
1
+9%
|
1
-25%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
0
-27%
|
0
-88%
|
0
+109%
|
(0)
N/A
|
(1)
-173%
|
(2)
-31%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||
Operating Expenses |
(3)
|
(4)
|
(4)
|
(2)
|
(1)
|
(1)
|
(0)
|
(2)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(5)
|
(7)
|
(6)
|
(6)
|
(9)
|
(9)
|
(11)
|
(13)
|
(13)
|
(14)
|
(12)
|
(10)
|
(7)
|
(8)
|
(11)
|
(11)
|
(11)
|
(10)
|
(10)
|
(10)
|
|
Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(3)
|
(5)
|
(8)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
|
Research & Development |
(2)
|
(3)
|
(2)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
0
|
(2)
|
(2)
|
(3)
|
(2)
|
(4)
|
(6)
|
(6)
|
(7)
|
(6)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
|
Other Operating Expenses |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Operating Income |
(2)
N/A
|
(3)
-59%
|
(3)
+1%
|
(1)
+56%
|
(0)
+61%
|
(0)
+13%
|
(0)
+33%
|
(2)
-800%
|
(0)
+90%
|
(0)
+33%
|
(0)
-56%
|
(0)
-52%
|
(1)
-137%
|
(3)
-189%
|
(4)
-71%
|
(5)
-16%
|
(3)
+49%
|
(1)
+59%
|
(5)
-342%
|
(6)
-30%
|
(7)
-14%
|
(8)
-18%
|
(8)
-2%
|
(9)
-8%
|
(9)
+6%
|
(7)
+20%
|
(4)
+36%
|
(6)
-34%
|
(10)
-79%
|
(11)
-7%
|
(11)
+6%
|
(11)
-1%
|
(11)
-6%
|
(12)
-2%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(2)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
Pre-Tax Income |
(2)
N/A
|
(3)
-59%
|
(2)
+10%
|
(1)
+46%
|
(1)
+32%
|
(0)
+48%
|
(2)
-413%
|
(3)
-9%
|
(1)
+75%
|
(1)
+22%
|
(0)
+12%
|
(0)
+11%
|
(1)
-126%
|
(3)
-210%
|
(5)
-66%
|
(7)
-62%
|
(3)
+61%
|
(2)
+24%
|
(5)
-118%
|
(6)
-28%
|
(7)
-15%
|
(8)
-20%
|
(9)
-1%
|
(9)
-7%
|
(9)
+6%
|
(7)
+20%
|
(4)
+37%
|
(6)
-32%
|
(10)
-86%
|
(11)
-9%
|
(11)
+6%
|
(11)
+0%
|
(11)
-6%
|
(12)
-3%
|
|
Net Income | |||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(2)
|
(3)
|
(2)
|
(1)
|
(0)
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(3)
|
(4)
|
(7)
|
(3)
|
(2)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(7)
|
(4)
|
(6)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
|
Net Income (Common) |
(2)
N/A
|
(3)
-65%
|
(2)
+17%
|
(1)
+68%
|
(0)
+39%
|
(0)
+95%
|
(2)
-8 450%
|
(3)
-83%
|
(1)
+53%
|
(1)
+66%
|
(0)
+12%
|
(0)
+11%
|
(1)
-126%
|
(3)
-210%
|
(4)
-55%
|
(7)
-74%
|
(3)
+61%
|
(2)
+24%
|
(5)
-118%
|
(6)
-28%
|
(7)
-15%
|
(8)
-20%
|
(9)
-1%
|
(9)
-7%
|
(9)
+6%
|
(7)
+20%
|
(4)
+37%
|
(6)
-32%
|
(10)
-86%
|
(11)
-9%
|
(11)
+6%
|
(11)
+0%
|
(11)
-6%
|
(12)
-3%
|
|
EPS (Diluted) |
-0.03
N/A
|
-0.05
-67%
|
-0.04
+20%
|
-0.01
+75%
|
0
N/A
|
0
N/A
|
-0.03
N/A
|
-0.03
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.02
-100%
|
-0.01
+50%
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.02
-100%
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|